Absolute Antibody系列 | Anti-A14 Vaccinia virus

代理廠牌：
原廠連結：
相關下載：	Ab00733-1.1 Anti-A14操作手冊

特點

Fc Silent™ Antibodies: Turning down the background noise

Fc Silent 抗體 | 只要訊號不要雜訊 (Engineered Fc Domain)

Absolute Antibody 提供一系列抗體商品，其中Fc Silent™ Antibodies系列；能有效降低非特異性Fc結合。Fc Silent™技術，為應用生物工程技術，將Fc receptors (FcγR, FcR)點突變，進而中止抗體與ADCC的功能；有效降低Fc所造成的背景訊號。

Fc Silent™抗體應用於免疫細胞時flow cytometry、immunohistochemistry (IHC)資料顯示，有效降低非特異性之Fc結合，所造成的背景值。(訂購抗體前，請確認選擇抗體是否有Fc Silent™修飾標誌)

Anti-A14 [BB5.2] 抗體 | 產品描述:

Recombinant monoclonal antibody to A14. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma BB5.2.

抗體名稱	Recombinant monoclonal antibody to A14. Vaccinia virus	相異名稱Vaccinia virus A14 phosphoprotein; virion membrane protein
抗體貨號	Ab00733-1.1 Anti-A14 [BB5.2]	特異性This antibody is specific for the vaccinia virus A14 phosphoprotein, which is expressed on the membranes of intracellular mature virions.
	Recombinant monoclonal antibody to A14. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma BB5.2.
免疫原	This antibody was produced by infecting a BALB/c mouse intranasally with WR.K1L–C7L–, a highly attentuated vaccinia virus. The mouse was subsequently challenged with intranasal inoculation of of wild type VACV, followed by intravenous injection with UV-inactivated VACV
應用注意	A14 was among one of a group of VAVC proteins that elicited strong polyclonal antibody responses, resulting in multiple clones of hybridomas being generated against the same protein, all of which were analysed with IF, IP and WB. These clones have not, as of yet, been individually described in published literatu

更多相關抗體Primary Antibodies

Product Name page	Expected Species Reactivity	Applications
Anti-A14 [BB5.2]	Vaccinia virus	WB; IP; IF
Anti-Vaccinia A33 glycoprotein [A2C7]	Vaccinia virus	IF; neutralization
Anti-Vaccinia L1 protein [M12b9 Fab]	Vaccinia virus	crystallization; BLI binding assay

↑回到頁首↑